REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 201 filers reported holding REATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,139,325 | +12.1% | 20,982 | 0.0% | 0.08% | +10.4% |
| Q1 2023 | $1,907,683 | +139.3% | 20,982 | 0.0% | 0.08% | +140.6% |
| Q4 2022 | $797,106 | +51.3% | 20,982 | 0.0% | 0.03% | +39.1% |
| Q3 2022 | $527,000 | -17.4% | 20,982 | 0.0% | 0.02% | -17.9% |
| Q2 2022 | $638,000 | -7.1% | 20,982 | 0.0% | 0.03% | 0.0% |
| Q1 2022 | $687,000 | +23.8% | 20,982 | -0.3% | 0.03% | +16.7% |
| Q4 2021 | $555,000 | -73.7% | 21,042 | +0.3% | 0.02% | -75.3% |
| Q3 2021 | $2,111,000 | -28.9% | 20,982 | 0.0% | 0.10% | -28.7% |
| Q2 2021 | $2,970,000 | +42.0% | 20,982 | 0.0% | 0.14% | +37.4% |
| Q1 2021 | $2,092,000 | -19.4% | 20,982 | 0.0% | 0.10% | -28.8% |
| Q4 2020 | $2,594,000 | +26.9% | 20,982 | 0.0% | 0.14% | +10.3% |
| Q3 2020 | $2,044,000 | -37.6% | 20,982 | 0.0% | 0.13% | -35.1% |
| Q2 2020 | $3,274,000 | +8.1% | 20,982 | 0.0% | 0.19% | -14.9% |
| Q1 2020 | $3,029,000 | -29.4% | 20,982 | 0.0% | 0.23% | +3.6% |
| Q4 2019 | $4,289,000 | +154.5% | 20,982 | 0.0% | 0.22% | +150.0% |
| Q3 2019 | $1,685,000 | -14.9% | 20,982 | 0.0% | 0.09% | -18.5% |
| Q2 2019 | $1,980,000 | +10.4% | 20,982 | 0.0% | 0.11% | +11.3% |
| Q1 2019 | $1,793,000 | +52.3% | 20,982 | 0.0% | 0.10% | +47.0% |
| Q4 2018 | $1,177,000 | -31.4% | 20,982 | 0.0% | 0.07% | -16.5% |
| Q3 2018 | $1,715,000 | +133.7% | 20,982 | 0.0% | 0.08% | +125.7% |
| Q2 2018 | $734,000 | +70.7% | 20,982 | 0.0% | 0.04% | +52.2% |
| Q1 2018 | $430,000 | -27.6% | 20,982 | 0.0% | 0.02% | -25.8% |
| Q4 2017 | $594,000 | -9.0% | 20,982 | 0.0% | 0.03% | -22.5% |
| Q3 2017 | $653,000 | -1.7% | 20,982 | 0.0% | 0.04% | -11.1% |
| Q2 2017 | $664,000 | +39.8% | 20,982 | 0.0% | 0.04% | +55.2% |
| Q1 2017 | $475,000 | – | 20,982 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |